Evidence map›Paper›PMID 25627015›Full record

ArticleThe Journal of antibiotics2015

Irciniastatin A, a pederin-type translation inhibitor, promotes ectodomain shedding of cell-surface tumor necrosis factor receptor 1.

Seiya Hirano, Hue Tu Quach, Tsubasa Watanabe, Naoki Kanoh, Yoshiharu Iwabuchi, Takeo Usui, Takao Kataoka

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seiya HiranoDepartment of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Kyoto, Japan.
Hue Tu QuachDepartment of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Kyoto, Japan.ORCID 0000000155711908
Tsubasa WatanabeDepartment of Organic Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Naoki KanohDepartment of Organic Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Yoshiharu IwabuchiDepartment of Organic Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Takeo UsuiFaculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan.
Takao KataokaDepartment of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinomaCell Line, TumorCell MembraneCell NucleusCell SurvivalCoumarinsGene Expression Regulation, NeoplasticHumansIntercellular Adhesion Molecule-1Lung NeoplasmsMolecular WeightNeoplasm ProteinsOsmolar ConcentrationProtein BiosynthesisProtein Synthesis InhibitorsAntineoplastic AgentsCoumarinsICAM1 protein, humanIntercellular Adhesion Molecule-1Neoplasm ProteinsProtein Synthesis InhibitorspsymberinReceptors, Tumor Necrosis Factor, Type I

Identifiers

PMID25627015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.